Synonyms |
β-D-Glucopyranoside, 4-[(1S,3aR,4R,6aR)-4-(3,4-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-2-methoxyphenyl; 4-[(1S,3aR,4R,6aR)-4-(3,4-Dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-2-methoxyphenyl β-D-glucopyranoside; Phyllyrin; β-D-Glucopyranoside, 4-[4-(3,4-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-2-methoxyphenyl, [1S-(1α,3aα,4β,6aα)]-; Phillygenin β-D-glucopyranoside; [1S-(1α,3aα,4β,6aα)]-4-[4-(3,4-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-2-methoxyphenyl-β-D-Glucopyranoside; Phillyroside |
IUPAC Name |
(2S,3R,4S,5S,6R)-2-[4-[(3R,3aR,6S,6aR)-3-(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
Molecular Weight |
534.55 |
Molecular Formula |
C27H34O11 |
Canonical SMILES |
COC1=C(C=C(C=C1)C2C3COC(C3CO2)C4=CC(=C(C=C4)OC5C(C(C(C(O5)CO)O)O)O)OC)OC |
InChI |
InChI=1S/C27H34O11/c1-32-17-6-4-13(8-19(17)33-2)25-15-11-36-26(16(15)12-35-25)14-5-7-18(20(9-14)34-3)37-27-24(31)23(30)22(29)21(10-28)38-27/h4-9,15-16,21-31H,10-12H2,1-3H3/t15-,16-,21+,22+,23-,24+,25-,26+,27+/m0/s1 |
InChIKey |
KFFCKOBAHMGTMW-LGQRSHAYSA-N |
Boiling Point |
730.4±60.0°C at 760 mmHg |
Melting Point |
166-168°C |
Flash Point |
395.5±32.9 °C |
Purity |
≥95% |
Density |
1.361±0.06 g/cm3 |
Solubility |
Soluble in DMSO (Slightly), Methanol (Slightly) |
Appearance |
Off-white to Pale Beige Solid |
Storage |
Store at -20°C under inert atmosphere |
Complexity |
757 |
Exact Mass |
534.21011190 |
Index Of Refraction |
1.596 |
In Vitro |
Phillyrin (1-5 μM; pretreatment 1 hour; 24 hours) inhibits high glucose-induced FAS protein significantly in HepG2 cells. Phillyrin (1-5 μM; pretreatment 1 hour; 24 hours) inhibits high glucose-induced FAS mRNA expression by suppressing SREBP-1c activation in human HepG2 hepatocytes. |
PSA |
145.53000 |
Target |
Cytochrome P450; Influenza Virus; Bacterial |
Vapor Pressure |
0.0±2.5 mmHg at 25°C |
XLogP3-AA |
0 |